PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2021
CASE
GlaxoSmithKline

GSK at ERS 2022: COPD network meta-analysis slides ruled misleading; MSL presence on promo stand not proven promotional

At ERS 2022, GSK-sponsored symposium slides on a COPD network meta-analysis were ruled misleading/unsubstantiated (Clauses 6.1, 6.2, 5.1). Allegations about MSLs acting…

2023
CASE
AUTH/3748/2/23 Otsuka ⭐ Case of the Week

Otsuka Europe website: outdated partner statement ruled inaccurate (AUTH/3748/2/23)

Otsuka’s β€œTherapy Areas in Europe” webpage still referenced working with partner Akebia on CKD anaemia after the agreement ended. PMCPA ruled the…

2023
CASE
AUTH/3794/7/23 Merck Serono

Merck Serono fertility event: co-chairs’ consultancy contracts not signed before services began (AUTH/3794/7/23)

PMCPA found Merck Serono failed to maintain high standards after two event co-chairs’ consultancy agreements were not agreed/signed in advance of services.…

2023
CASE
AUTH/3779/6/23 Boehringer Ingelheim

AUTH/3779/6/23 & AUTH/3780/6/23: Ex-employee complaint about alliance promotional material approval process (BI/Lilly) – No breach

Ex-employee alleged BI/Lilly alliance PMAP SOP and training were not accessible/controlled and that β€œagreements outside PMAP” existed. Panel found allegations not evidenced;…

2024
CASE
AUTH/3870/1/24 AstraZeneca

AUTH/3870/1/24: Complainant v AstraZeneca β€” Allegations about clinical trial material (Out of scope)

PMCPA case AUTH/3870/1/24 against AstraZeneca concerned allegations about clinical trial material. The matter was found outwith the scope of the ABPI Code;…

2023
CASE
AUTH/3817/9/23 AstraZeneca

AUTH/3817/9/23: AstraZeneca SENTINEL Plus website and MART references β€” no breach

Complaint alleged MART references on AstraZeneca’s SENTINEL Plus HCP website indirectly promoted Symbicort and therefore needed PI and an AE reporting statement.…

2023
CASE
AUTH/3829/9/23 GlaxoSmithKline ⭐ Case of the Week

AUTH/3829/9/23: Complainant v GSK β€” event website sponsorship declaration (no breach)

Complaint alleged GSK sponsorship of an HCP event wasn’t disclosed on the homepage or registration pages. Panel found sponsorship was sufficiently clear…

2023
CASE
AUTH/3856/11/23 Idorsia

PMCPA AUTH/3856/11/23: Complainant v Idorsia (Quviviq) β€” β€˜chronic insomnia’ wording in GP website ads (No breach)

Two Idorsia banner ads for Quviviq used the term β€œchronic insomnia”. Complaint alleged off-licence promotion vs SmPC. Panel found authoritative definitions aligned…

2024
CASE
AUTH/3888/4/24 Pfizer

Pfizer: Covid-19 vaccine Phase 3 efficacy tweets ruled promotional pre-authorisation and in breach of undertaking (AUTH/3888/4/24)

Pfizer UK’s 2020 Twitter thread on Phase 3 Covid-19 vaccine results (plus linked BioNTech content and press release) was ruled promotional before…

2024
CASE
AUTH/3907/05/24 Jazz Pharmaceuticals

Jazz Pharmaceuticals UK breached transparency rules for patient organisation-funded family guide (AUTH/3907/05/24)

Jazz funded a patient organisation’s β€œFamily Guide” via unrestricted grants. The funding declaration appeared in small font on page 5 and the…

2024
CASE
AUTH/3903/5/24 GlaxoSmithKline

AUTH/3903/5/24: Complainant v GSK (Blenrep website safety claim) – No breach

Complaint challenged a Blenrep website claim (β€œgenerally well tolerated and manageable safety profile”) as misleading/unqualified. Panel found the claim sufficiently supported and…

2018
CASE
AUTH/3008/1/18 Pharmasure

AUTH/3008/1/18: Teva v Pharmasure – chocolate hamper provided to health professionals

A Pharmasure representative delivered a substantial high street chocolate hamper to a fertility unit team. The Panel ruled it was an unacceptable…

2008
CASE
AUTH/2114/4/08 Reckitt Benckiser Healthcare

AUTH/2114/4/08: Pharmacist complaint about β€œReflux super-suppressant” claim for Gaviscon Advance (BMJ advertisement)

A pharmacist challenged the strapline β€œReflux super-suppressant” in a BMJ advert for Gaviscon Advance. The Panel found it implied unsubstantiated general superiority…

2008
CASE
AUTH/2162/8/08 Galen

AUTH/2162/8/08 ProStrakan v Galen: Promotion of Calceos (taste, adherence and fracture-risk claims)

A competitor complaint upheld that a Calceos leavepiece misleadingly implied taste-driven preference, long-term adherence and fracture-risk benefits, and used references that did…

2008
CASE
AUTH/2147/7/08 Sanofi ⭐ Case of the Week

AUTH/2147/7/08: GlaxoSmithKline v Sanofi Pasteur MSD – Gardasil press release and PR agency emails

A Gardasil press release and follow-up PR emails after the UK chose Cervarix for the national HPV programme were ruled misleading, exaggerated…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training